Photo: Shutterstock
FDA Approves First Ever Covid-19 Breath Test
The US Food and Drug Administration (FDA) has granted EUA to the first-ever Covid-19 breath test. The InspectIR Covid-19 Breathalyzer can produce results in less than three minutes. The device can separate and identify chemical mixtures, and detect five compounds associated with Sars-CoV2 infection in the exhaled breath of a person. The diagnostic test has more than 90% accuracy in identifying both positive and negative samples.
Tags: Covid-19, Covid-19 Test, Coronavirus Pandemic, Emergency Use Authorization, emergency use
Courtesy: CNN
Photo: Business Standard
WHO Requests Explanations On Covaxin; To Reconvene On November 3 For Final Review
WHO announced on October 26, that Technical-Advisory-Group (TAG) for Emergency-Use-Listing (EUL) has made the decision that added clarifications from Bharat-Biotech are required before a final EUL risk-benefit assessment for global use of Covaxin can be conducted. WHO stated that TAG “expects to receive these clarifications by the end of this week, and aims to reconvene on November 3”. Covaxin's acceptance by foreign countries is contingent… read-more
Tags: Covaxin, Bharat biotech, WHO, Emergency Use Authorization
Courtesy: The Indian Express
Photo: The Print
Ahmedabad-Based Zydus Cadila's Covid Vaccine Awaits Govt Approval
After conducting the largest clinical trials in more than 50 centers, Zydus Cadila's three-dose Covid vaccine "ZyCoV-D" may soon get the government's approval for emergency use in India. The Gujarat-based pharmaceutical company has been listed for emergency use authorization (EAU) with the Indian Drug regulator and is likely to produce around 10-12 crore doses in a year. Reportedly, the ZyCoV-D vaccination will be administered to the adults… read-more
Tags: Zydus Cadila, Covid-19, Covid Vaccination, Emergency Use Authorization
Courtesy: ANI
Photo: The Financial Express
Zydus COVID-19 Vaccine For Children To Launch Shortly In India
The government on June 27 declared that the vaccination process for children aged between 12 to 18 may start by July-end or August as the trials for Zydus Cadila is almost complete. The Zydus Cadila vaccine Zy-CoV-D will soon apply for authorisation for emergency use to the Drugs Controller General of India. The vaccine is asserted to be safe for use in both children and adults.
Tags: Zydus Cadila, Coronavirus Vaccines, DRUG CONTROLLER GENERAL OF INDIA, Emergency Use Authorization
Courtesy: The Times of India
Photo: The Economic Times
Vaccine: Pfizer Withdraws Emergency Use Authorization Plea In India
American pharmaceutical MNC Pfizer has withdrawn the Emergency Use Authorization application for its COVID-19 vaccine in India. Pfizer on February 5 said the decision had been taken after it met with the Drug Regulatory Authority of India. Withdrawing its request, the vaccine developer said the regulator has sought for extra information. However, Pfizer, which was first to seek emergency approval for the vaccine in India, has confirmed to re-… read-more
Tags: Pfizer-BioNTech Vaccine, Emergency Use Authorization, Covid Vaccine
Courtesy: NDTV
